Milestone Pharmaceuticals (MIST) Total Current Liabilities (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Total Current Liabilities of $20.9 million for Q1 2026, up 49.82% on a QoQ basis from $14.0 million in Q4 2025, and up 61.57% year-over-year from $13.0 million in Q1 2025.
Milestone Pharmaceuticals (MIST) Total Current Liabilities (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $20.9 million for Q1 2026.
- Quarterly Total Current Liabilities rose 61.57% year-over-year to $20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (up 61.57% YoY) and the FY2025 annual result came in at $14.0 million, up 72.03% from the prior year.
- Total Current Liabilities was $20.9 million for Q1 2026 at Milestone Pharmaceuticals, up from $14.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $20.9 million in Q1 2026 and bottomed at $4.1 million in Q1 2024.
- A 5-year average of $8.3 million and a median of $7.2 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities slumped 48.14% — and 2025, when it surged 213.87%.
- Milestone Pharmaceuticals' Total Current Liabilities stood at $6.1 million in 2022, then climbed by 17.71% to $7.2 million in 2023, then increased by 12.46% to $8.1 million in 2024, then jumped by 72.03% to $14.0 million in 2025, then surged by 49.82% to $20.9 million in 2026.
- Business Quant data shows MIST's Total Current Liabilities at $20.9 million in Q1 2026, $14.0 million in Q4 2025, and $10.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 20.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.94 Mn |
| Dec 31, 2025 | 13.98 Mn |
| Sep 30, 2025 | 10.52 Mn |
| Jun 30, 2025 | 9.28 Mn |
| Mar 31, 2025 | 12.96 Mn |
| Dec 31, 2024 | 8.13 Mn |
| Sep 30, 2024 | 5.26 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | 7.23 Mn |
| Sep 30, 2023 | 8.11 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Mar 31, 2023 | 7.96 Mn |
| Dec 31, 2022 | 6.14 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 4.26 Mn |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 6.78 Mn |
| Sep 30, 2021 | 5.85 Mn |
| Jun 30, 2021 | 5.33 Mn |